According to recent research in London, scientists have found that the structure of an enzyme could have a clear role in understanding the mutations responsible for causing diabetes and other diseases, such as cancer .
This particular enzymen, known as p300/CBP, could therefore have potential usage to design and develop drugs to treat diabetes, HIV, heart disease and cancer The study was reportedly led by an expert at the John Hopkins University School of Medicine in Baltimore .
Using complex research procedures the research team found that the enzymen, which has been identified for over a decade, could be very useful in the future. The function of the enzyme apparently explains why mutations could lead to disease.
The fresh research appeared the most recent issue of the journal, Nature.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…